查詢結果分析
相關文獻
- 以證據醫學(Evidence Based Medicine)的方法來評估「類固醇在預防早產兒慢性肺疾病發生」的效果
- 在低體重早產兒出生後使用類固醇治療預防慢性肺病變
- 早期使用類固醇以預防慢性肺部病變
- Antenatal Steroids and Blood Pressure in Very Low Birth Weight Infants
- 早期使用吸入性budesonide對於支氣管肺發育不良的預防
- 產前類固醇在預防早產兒呼吸窘迫症候群之應用
- Could Premature Infants Benefit from Single Dose Antenatal Betamethasone?
- 產前使用Betamethasone:投藥到分娩的期間較長會增加<28周之早產兒出現嚴重的腦室內出血之發病率
- 出生後使用全身性皮質類固醇與支氣管肺發育不良及無腦性麻痺存活率的關係
- 一位經產婦努力成為早產兒母親的經驗
頁籤選單縮合
| 題 名 | Could Premature Infants Benefit from Single Dose Antenatal Betamethasone?=產前單劑類固醇是否對早產兒有益? |
|---|---|
| 作 者 | 黃啟銘; 謝武勳; 陳倩儀; 曹伯年; 周弘傑; | 書刊名 | Clinical Neonatology |
| 卷 期 | 14:2 2007.12[民96.12] |
| 頁 次 | 頁50-54 |
| 分類號 | 417.5171 |
| 關鍵詞 | 類固醇; 早產兒; Premature infants; Antenatal corticosteroids; Surfactant; Neonatal outcome; |
| 語 文 | 英文(English) |
| 英文摘要 | Objective: To evaluate the effectiveness of single dose antenatal betamethasone on the neonatal outcome of preterm infants. Patients and Methods: Details of preterm infants born between 24-34 weeks' gestational age between march1, 2001 and July 31, 2006 were collected via chart review. The premature infants enrolled were divided into two groups: infants whose mothers received 12 mg of betamethasone once before delivery were classified as the single dose antenatal betamethasone (SAB) group and those without exposure to antenatal corticosteroids were categorized as the control group. The gestational age, birth body weight, neonatal outcome, and requirement of oxygen and mechanical ventilation were analyzed. Results: One hundred and thirty four premature infants were enrolled, with 33 infants classified as the SAB group and 101 infants as the control group. The requirement for surfactants and vasopressors was significantly lower in the SAB group. Logistic regression adjusted for gestational age and birth body weight still revealed the same effects. Conclusion: SAB can reduce the need for surfactants and vasopressors in premature infants born at 24-34 weeks gestational age. Obstetricians should not hesitate to prescribe antenatal corticosteroids even if completion of the standard treatment course is not feasible. |
本系統中英文摘要資訊取自各篇刊載內容。